{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:05:26Z","timestamp":1784264726556,"version":"3.55.0"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>False-negative endoscopic biopsy may delay the diagnosis of infiltrative gastric cancer, particularly in poorly differentiated or signet-ring cell phenotypes. We report a 56-year-old man with progressive abdominal distension, nausea, vomiting, weight loss, and epigastric pain. Three endoscopic biopsies performed before and after transfer to our hospital showed chronic inflammation without definite malignancy. F-18 FDG PET\/CT demonstrated slightly increased and indistinct uptake compared with the liver in the thickened gastric antrum wall, whereas subsequent Ga-68 FAPI-04 PET\/CT showed intense uptake with clearer lesion delineation. Because of progressive gastric outlet obstruction and persistent clinical suspicion, distal gastrectomy was performed for symptom relief and definitive diagnosis. Final histopathology confirmed poorly differentiated gastric adenocarcinoma with partial signet-ring cell morphology. The patient subsequently received postoperative XELOX chemotherapy and remained clinically stable at the 7-months follow-up. This case suggests that Ga-68 FAPI-04 PET\/CT may serve as a problem-solving adjunct when repeated endoscopic biopsies are non-diagnostic but suspicion for infiltrative gastric cancer persists.<\/jats:p>","DOI":"10.3389\/fmed.2026.1899076","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:23:28Z","timestamp":1784262208000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Ga-68 FAPI-04 PET\/CT detection of repeatedly biopsy-negative poorly differentiated gastric adenocarcinoma: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhipeng","family":"Cheng","sequence":"first","affiliation":[{"name":"Graduate School, Hebei North University","place":["Zhangjiakou, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Chang","sequence":"additional","affiliation":[{"name":"Graduate School, Hebei North University","place":["Zhangjiakou, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixia","family":"Sui","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/eus.eus_20_18","article-title":"The role of EUS in missed and known linitis plastica","volume":"9","author":"Khara","year":"2020","journal-title":"Endosc Ultrasound."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.3748\/wjg.v21.i12.3607","article-title":"Endoscopic ultrasound-guided deep and large biopsy for diagnosis of gastric infiltrating tumors with negative malignant endoscopy biopsies","volume":"21","author":"Zhou","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.2967\/jnumed.115.160580","article-title":"Relationship between F-18 FDG uptake on PET and recurrence patterns after curative surgical resection in patients with advanced gastric cancer","volume":"56","author":"Lee","year":"2015","journal-title":"J Nucl Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2967\/jnumed.115.171165","article-title":"Relationship between F-18 FDG PET\/CT findings and HER2 expression in gastric cancer","volume":"57","author":"Chen","year":"2016","journal-title":"J Nucl Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00259-021-05494-x","article-title":"Head-to-head comparison of Ga-68 Ga-FAPI-04 and F-18 FDG PET\/CT in evaluating the extent of disease in gastric adenocarcinoma","volume":"49","author":"Kuten","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/MNM.0000000000001489","article-title":"Comparison of F-18 FDG PET\/CT and Ga-68 FAPI-04 PET\/CT in the staging and restaging of gastric adenocarcinoma","volume":"43","author":"Gundogan","year":"2022","journal-title":"Nucl Med Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1007\/s00259-022-05799-5","article-title":"Ga-68 DOTA-FAPI-04 PET\/CT in the evaluation of gastric cancer: comparison with F-18 FDG PET\/CT","volume":"49","author":"Lin","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1007\/s00330-022-09321-1","article-title":"Utility of Ga-68 FAPI-04 and F-18 FDG dual-tracer PET\/CT in the initial evaluation of gastric cancer","volume":"33","author":"Miao","year":"2023","journal-title":"Eur Radiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e230195","DOI":"10.1148\/rycan.230195","article-title":"Assessing the value of Ga-68 FAPI PET\/CT in gastric mucinous adenocarcinoma or signet ring cell carcinoma","volume":"6","author":"Sun","year":"2024","journal-title":"Radiol Imaging Cancer."},{"key":"B11","doi-asserted-by":"publisher","first-page":"11192","DOI":"10.3390\/ijms222011192","article-title":"Head-to-head comparison of fibroblast activation protein inhibitors radiotracers versus F-18 FDG in oncology: a systematic review","volume":"22","author":"Treglia","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e220749","DOI":"10.1148\/radiol.220749","article-title":"FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease","volume":"306","author":"Mori","year":"2023","journal-title":"Radiology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13550-021-00761-2","article-title":"Clinical results of fibroblast activation protein-specific PET for nonmalignant indications: systematic review","volume":"11","author":"Windisch","year":"2021","journal-title":"EJNMMI Res."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1899076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:23:29Z","timestamp":1784262209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1899076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":13,"alternative-id":["10.3389\/fmed.2026.1899076"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1899076","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"1899076"}}